HTA65 The Relationship between Globotriaosylceramide (GB3), Globotriaosylsphingosine (LYSO-GB3) and Disease-Related Clinical Events in Patients with Fabry Disease
Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.1197
https://www.valueinhealthjournal.com/article/S1098-3015(22)01398-5/fulltext
Title :
HTA65 The Relationship between Globotriaosylceramide (GB3), Globotriaosylsphingosine (LYSO-GB3) and Disease-Related Clinical Events in Patients with Fabry Disease
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01398-5&doi=10.1016/j.jval.2022.04.1197
First page :
Section Title :
Open access? :
No
Section Order :
11070